Person in grocery aisle
·
4 MIN READ

Removing naloxone’s Rx status is an essential step to save lives

As the drug-overdose epidemic worsens, there is no moral, medical or safety-related reason for keeping naloxone locked under prescription regulations.

Overdose Epidemic
·
8 MIN READ

Feb. 18, 2022: National Advocacy Update

CMS urged to allow more time to review draft cost measures and more in the latest National Advocacy Update.

Advocacy Update
·
2 MIN READ

AMA urges Administration to remove naloxone from behind the counter

Removing the prescription status of naloxone as an essential step to save lives from opioid-related overdose, helps to make naloxone available to patients.

Press Releases
·
3 MIN READ

AMA, Manatt Health unveil toolkit to combat drug overdoses

The AMA and Manatt Health release a toolkit to guide states on removing barriers to evidence-based patient care.

Press Releases
Exterior of an emergency room entrance
·
4 MIN READ

M1s help spot emergency patients who can benefit from naloxone

Learn how first-year medical students can add value and learn about addiction medicine by screening patients to ID those at risk of an opioid-related overdose.

Overdose Epidemic
·
5 MIN READ

2022 a critical year to address worsening drug-overdose crisis

In the shadow of COVID-19, our nation’s drug-overdose epidemic is worsening. We need policymakers to take concrete actions in the new year to reverse this devastating trend.

series
Leadership
Leadership Viewpoints
Outdoor Emergency Room sign
·
4 MIN READ

Embracing harm reduction in the emergency department

Learn about work by Phoenix emergency physicians to get naloxone directly into the hands of patients at risk of overdose.

Overdose Epidemic
Ambulance
·
4 MIN READ

Ending the stigma of opioid-use disorder in the emergency department

Need for cultural shift in medicine on opioid-use disorder is long overdue. Learn about one emergency physician’s journey to understanding.

Overdose Epidemic
·
3 MIN READ

Dec. 3, 2021: State Advocacy Update

AMA urges nation’s naloxone manufactures to make product OTC and more in the latest State Advocacy Update.

Advocacy Update